Intra-Cellular Therapies
ITCI
#1342
Rank
A$21.39 B
Marketcap
$201.27
Share price
-0.05%
Change (1 day)
78.97%
Change (1 year)

Market capitalization of Intra-Cellular Therapies (ITCI)

Market cap: A$21.39 Billion

As of February 2025 Intra-Cellular Therapies has a market cap of A$21.39 Billion. This makes Intra-Cellular Therapies the world's 1342th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Intra-Cellular Therapies from 2013 to 2025

End of year Market Cap

Year Marketcap Change
2025A$21.39 B47.97%
2024A$14.46 B42.95%
2023A$10.11 B37.37%
2022A$7.36 B25.23%
2021A$5.88 B76.74%
2020A$3.32 B22.33%
2019A$2.72 B206.47%
2018A$0.88 B-12.32%
2017A$1.01 B11.76%
2016A$0.90 B-71.57%
2015A$3.18 B400.87%
2014A$0.63 B28.04%
2013A$0.49 B

End of Day market cap according to different sources

On Feb 20th, 2025 the market cap of Intra-Cellular Therapies was reported to be:

A$21.33 Billion
by Nasdaq info icon info icon
A$21.39 Billion
by CompaniesMarketCap info icon info icon
A$21.39 Billion
by Yahoo Finance info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
A$0.13 B-99.36%๐Ÿ‡บ๐Ÿ‡ธ USA
A$41.09 M-99.81%๐Ÿ‡บ๐Ÿ‡ธ USA
A$1.73 B-91.91%๐Ÿ‡บ๐Ÿ‡ธ USA